Human papillomavirus vaccine [5]

New England Journal of Medicine

Volumn 357, Issue 11, 2007, Pages 1155-

  Suba, Eric J ^a   Raab, Stephen S ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE; PAPILLOMA VIRUS VACCINE; UNCLASSIFIED DRUG;

CANCER PREVENTION; CANCER SCREENING; LETTER; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; WART VIRUS; ALPHAPAPILLOMAVIRUS; DEVELOPING COUNTRY; FEMALE; HUMAN; NOTE; UTERINE CERVIX TUMOR; VIRUS INFECTION;

ALPHAPAPILLOMAVIRUS; DEVELOPING COUNTRIES; FEMALE; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS;

EID: 34548722060     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (2)

1. Agosti JM, Goldie SJ. Introducing HPV vaccine in developing countries - key challenges and issues. N Engl J Med 2007;356:1908-10.
2. Suba EJ, Donnelly AD, Furia LM, Huynh ML, Raab SS. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches. Diagn Cytopathol 2007;35:187-91.